The Health Resources and Services Administration today released a proposed rule that would implement an Affordable Care Act provision requiring a binding administrative dispute resolution process for 340B Drug Pricing Program participants who claim they have been overcharged for drugs purchased through the program. Under the proposed process, which also would be available to drug manufacturers, a decision-making body within the Department of Health and Human Services would review and resolve the claims. The proposed rule will be published in the Aug. 12 Federal Register with comments accepted through Oct. 11. AHA staff are reviewing the rule, and member hospitals that are 340B participants will receive more information.

Related News Articles

News
Reps. Peter Welch, D-Vt., Suzan DelBene, D-Wash., Darin LaHood, R-Ill., and Brad Wenstrup, R-Ohio, yesterday reintroduced the Value in Health Care Act, AHA-…
News
The Centers for Medicare & Medicaid Services today advised clinicians in the Medicare Quality Payment Program who earned but did not receive an alternative…
Headline
Congress should not extend Medicare sequestration to help pay for the bipartisan infrastructure framework because health care providers cannot sustain…
Headline
The Centers for Medicare & Medicaid Services is accepting comments through Aug. 11 on whether to establish a national Medicare coverage policy for…
Headline
The AHA and other national hospital organizations today urged Senate leadership and senators supporting a bipartisan $1.2 trillion infrastructure agreement…
Headline
The Medicare Payment Advisory Commission yesterday issued its June report to Congress on refinements to Medicare payment systems and issues affecting the…